NCT02917018View on ClinicalTrials.gov

Effect of Dexmedetomidine on Stress Response and Emergence Agitation During Laparoscopic Surgery

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Stress Response
Interventions
DRUG

Dexmedetomidine

Group I will receive 1 ug/kg, group II will receive 0.75 ug/kg and group III will receive 0.5 ug/kg) diluted to 50 ml NaCl 0.9% by syringe pump over 20 minutes before end of surgery.

Trial Locations (1)

71515

Assiut university hospital, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT02917018 - Effect of Dexmedetomidine on Stress Response and Emergence Agitation During Laparoscopic Surgery | Biotech Hunter | Biotech Hunter